To explore potential relationships between FASN expression and clinicopathological features of ccRCC patients, we used 533 ccRCC samples and 72 adjacent normal samples from TCGA cohort and found significantly increased FASN mRNA expression in ccRCC samples compared with normal samples (*p < 0.05; Figure 1A). The gene discussed is FASN; the disease is nonpapillary renal cell carcinoma.